Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 4196460, 9 pages
http://dx.doi.org/10.1155/2016/4196460
Research Article

Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids

1Department of Transplant Medicine, Oslo University Hospital, P.O. Box 4950, 0424 Oslo, Norway
2Institute for Surgical Research, Oslo University Hospital, P.O. Box 4950, 0424 Oslo, Norway
3Institute of Clinical Medicine, University of Oslo, P.O. Box 1171, Blindern, 0318 Oslo, Norway
4Department of Pharmacology, Oslo University Hospital, P.O. Box 4950, 0424 Oslo, Norway
5Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Box 815, 75108 Uppsala, Sweden
6Department of Clinical Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University Hospital, 75185 Uppsala, Sweden
7School of Pharmacy, University of Oslo, P.O. Box 1171, Blindern, 0318 Oslo, Norway

Received 30 September 2015; Revised 20 December 2015; Accepted 24 December 2015

Academic Editor: Laurent Crenier

Copyright © 2016 Kristine Kloster-Jensen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Kristine Kloster-Jensen, Afaf Sahraoui, Nils Tore Vethe, et al., “Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids,” Journal of Diabetes Research, vol. 2016, Article ID 4196460, 9 pages, 2016. https://doi.org/10.1155/2016/4196460.